Cytokine-Based Immunotherapy for Advanced Kidney Cancer: Past Results and Future Perspectives in the Era of Molecularly Targeted Agents

Until recently, immunotherapy has been the only therapeutic option available for patients with advanced kidney cancer, even though different choices were often made on the two sides of the Atlantic Ocean. The absence of alternatives made different immunotherapeutic approaches common practice, even w...

Descripción completa

Detalles Bibliográficos
Autores principales: Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Bonomi, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2007
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901142/
https://www.ncbi.nlm.nih.gov/pubmed/17619768
http://dx.doi.org/10.1100/tsw.2007.154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901142/
https://www.ncbi.nlm.nih.gov/pubmed/17619768
http://dx.doi.org/10.1100/tsw.2007.154

Ejemplares similares